Daniel Steinberg, MD
Interventional Cardiology · Charleston, SCNPI 1134394398
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 44.0% of the total. Reporting peaked in 2019 at $141,332 and has fallen 64.8% since, to $49,700 in 2025. Among interventional cardiology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 879 payments — averaging $695.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$269K
- Boston Scientific$197K
- Abbott$50K
- Shockwave Medical, Inc$27K
- Edwards Lifesciences$26K
- Terumo Medical Corporation$22K
- plus $20K from 20 others
Across 94 payments — averaging $5207.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$334K
- Medtronic$124K
- Abbott$26K
- Edwards Lifesciences$6K
What the payments were for
- Consulting fees$130,15021%
- Speaking & faculty fees$345,15756%
- Travel & lodging$89,06515%
- Food & beverage$47,0088%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 242 | $269,002 |
| Boston Scientific | 312 | $196,709 |
| Abbott | 85 | $50,360 |
| Shockwave Medical, Inc | 40 | $26,925 |
| Edwards Lifesciences | 73 | $25,975 |
| Terumo Medical Corporation | 24 | $22,167 |
| Siemens Medical Solutions USA, Inc. | 20 | $8,695 |
| Ancora Heart, Inc. | 15 | $4,032 |
| Biotronik Inc. | 14 | $2,164 |
| Livanova USA, Inc. | 3 | $1,660 |
| Teleflex LLC | 6 | $683 |
| Recor Medical Inc | 7 | $652 |
| Angiodynamics, Inc. | 4 | $494 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $406 |
| Cardiva Medical, Inc. | 15 | $379 |
| Abiomed | 2 | $259 |
| Jenavalve Technology, Inc. | 1 | $202 |
| Acist Medical Systems, Inc. | 1 | $141 |
| Biosense Webster, Inc. | 1 | $111 |
| Zimmer Biomet | 1 | $103 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Novartis | 3 | $75 |
| Heartflow, Inc. | 1 | $26 |
| Opsens Inc. | 1 | $22 |
| Stryker | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$205,455
- COREVALVE EVOLUT R$59,070
- GENERAL VASCULAR ACCESS$50,191
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$26,357
- CROSSBOSS$19,000
- GENERAL - STRUCTURAL HEART$17,916
- GENERAL - THERAPIES$14,664
- TR Band$13,118
- Optitorque$12,277
- Heartrail$12,277
- Glidesheath$12,277
- Edwards SAPIEN 3 Transcatheter Heart Valve$11,524
- Watchman$10,551
- LOTUS EDGE$10,075
- ROTABLATOR$8,496
- Sentinel$8,045
- GENERAL BALLOONS$7,500
- Artis Q$7,182
- AccuCinch$3,852
- PASCAL$1,917
How this compares
$611,380 in reported general payments places this provider in the 95th percentile of 117 interventional cardiology providers in South Carolina.
See all interventional cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $33,616 |
| JardianceEmpagliflozin | 14 | $14,372 |
| AtacandCandesartan Cilexetil | 12 | $5,793 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 31 | $431 |
| ClopidogrelClopidogrel Bisulfate | 17 | $323 |
| Metoprolol Succinate | 29 | $290 |
| Rosuvastatin Calcium | 18 | $221 |
| Carvedilol | 47 | $218 |
| Atorvastatin Calcium | 36 | $205 |
| Metoprolol Tartrate | 14 | $130 |
| Amlodipine Besylate | 17 | $112 |
| Lisinopril | 11 | $48 |
| Warfarin Sodium | 14 | $34 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Charleston
- Anbukarasi MaranCharleston$132K
- Lars RunquistCharleston$54K
- Matthew O'SteenCharleston$45K
- Scott WoodfieldCharleston$22K
- Jeffrey RiederCharleston$14K
- Fred KraininCharleston$9K
- Brian BrownSpartanburg$389K
- Nicholas AmorosoPawleys Island$283K
- Robert LeonardiWest Columbia$203K
- Jesse JorgensenGreenville$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.